Advancing solid-state batteries towards commercial reality

Ilika Plc

Ilika plc is positioning itself as a European contender in the race to commercialise solid-state batteries, a technology widely regarded as a potential successor to conventional lithium-ion systems.

Solid-state batteries replace liquid electrolytes with solid materials, aiming to improve safety, energy density and operational life.

The company operates a dual-platform model. Its Stereax range targets miniature, high-value applications such as medical implants and industrial sensing devices. These markets demand reliability, compact form factors and long service life, characteristics that align with solid-state design advantages.

At the larger end of the spectrum, Ilika is developing its Goliath cells for electric vehicle and high-energy applications. Automotive adoption represents a materially larger opportunity but also carries higher execution risk. Cell capacity scaling, consistency of output and compatibility with existing manufacturing processes are central hurdles. Ilika has moved to produce larger-format prototype cells on an automated pilot line, signalling progress from research to repeatable fabrication.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search